购物车
- 全部删除
- 您的购物车当前为空
JNK2-IN-1(Compound J27)是一款具有抗炎活性的JNK2抑制剂,其解离常数为79.2 μM。该化合物能通过阻断NF-κB/MAPK信号通路来降低肿瘤坏死因子α(TNF-α)和白细胞介素6(IL-6)的释放,从而减轻脂多糖(LPS)引起的急性肺损伤(ALI)及脓毒症症状。
JNK2-IN-1(Compound J27)是一款具有抗炎活性的JNK2抑制剂,其解离常数为79.2 μM。该化合物能通过阻断NF-κB/MAPK信号通路来降低肿瘤坏死因子α(TNF-α)和白细胞介素6(IL-6)的释放,从而减轻脂多糖(LPS)引起的急性肺损伤(ALI)及脓毒症症状。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | JNK2-IN-1 (Compound J27), a selective JNK2 inhibitor with a dissociation constant (Kd) of 79.2 µM, exhibits anti-inflammatory effects by attenuating TNF-α and IL-6 secretion via inhibition of the NF-κB/MAPK pathway. It effectively mitigates symptoms associated with LPS-induced acute lung injury (ALI) and sepsis [1]. |
分子量 | 522.55 |
分子式 | C30H26N4O5 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容